Total Payments
$7,742
2024 Payments
$642.86
Companies
15
Transactions
67
Medicare Patients
530
Medicare Billing
$47,463
Payment Breakdown by Category
Other$5,435 (70.2%)
Food & Beverage$1,217 (15.7%)
Consulting$690.00 (8.9%)
Education$400.33 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $5,200 | 1 | 67.2% |
| Food and Beverage | $1,217 | 24 | 15.7% |
| Consulting Fee | $690.00 | 1 | 8.9% |
| Education | $400.33 | 36 | 5.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $235.00 | 5 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | $5,435 | 6 | $0 (2023) |
| Genentech USA, Inc. | $690.00 | 1 | $0 (2023) |
| Biogen, Inc. | $499.72 | 8 | $0 (2024) |
| Cadwell Industries, INC | $439.79 | 7 | $0 (2024) |
| PTC Therapeutics, Inc. | $271.33 | 31 | $0 (2019) |
| NS Pharma, Inc. | $103.97 | 1 | $0 (2023) |
| CSL Behring | $51.19 | 2 | $0 (2021) |
| Amylyx Pharmaceuticals, Inc. | $49.09 | 1 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $44.59 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $39.09 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $642.86 | 14 | Biogen, Inc. ($339.08) |
| 2023 | $1,005 | 6 | Genentech USA, Inc. ($690.00) |
| 2022 | $75.00 | 1 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($75.00) |
| 2021 | $5,228 | 2 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($5,200) |
| 2020 | $120.00 | 3 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($120.00) |
| 2019 | $589.78 | 37 | PTC Therapeutics, Inc. ($271.33) |
| 2018 | $24.20 | 1 | Biogen, Inc. ($24.20) |
| 2017 | $58.24 | 3 | Grifols USA, LLC ($32.55) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Cadwell Industries, INC | — | Food and Beverage | Cash or cash equivalent | $71.76 | General |
| 11/13/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Education | Cash or cash equivalent | $31.10 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | CATALYST PHARMACEUTICALS, INC. | AGAMREE (Drug) | Education | Cash or cash equivalent | $13.49 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $138.19 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Biogen, Inc. | QALSODY (Drug), SPINRAZA, SKYCLARYS | Food and Beverage | In-kind items and services | $96.73 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Neurology | ||||||
| 05/02/2024 | Biogen, Inc. | QALSODY (Drug), SPINRAZA, SKYCLARYS | Food and Beverage | In-kind items and services | $69.86 | General |
| Category: Neurology | ||||||
| 04/24/2024 | Biogen, Inc. | QALSODY (Drug), SPINRAZA, SKYCLARYS | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Neurology | ||||||
| 04/24/2024 | Biogen, Inc. | QALSODY (Drug), SPINRAZA, SKYCLARYS | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: Neurology | ||||||
| 04/22/2024 | Cadwell Industries, INC | — | Education | Cash or cash equivalent | $44.17 | General |
| 04/22/2024 | Cadwell Industries, INC | — | Food and Beverage | Cash or cash equivalent | $39.21 | General |
| 04/22/2024 | Cadwell Industries, INC | — | Food and Beverage | Cash or cash equivalent | $32.91 | General |
| 02/23/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.05 | General |
| 01/30/2024 | Amylyx Pharmaceuticals, Inc. | RELYVRIO (Drug) | Food and Beverage | In-kind items and services | $49.09 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2023 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $136.44 | General |
| Category: Neurology | ||||||
| 10/19/2023 | NS Pharma, Inc. | VILTEPSO (Drug) | Food and Beverage | In-kind items and services | $103.97 | General |
| Category: PEDIATRIC NEUROLOGY | ||||||
| 08/29/2023 | Genentech USA, Inc. | Evrysdi (Drug) | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| Category: Neurology | ||||||
| 07/28/2023 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| 06/08/2023 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.64 | General |
| 02/17/2023 | Cadwell Industries, INC | — | Food and Beverage | Cash or cash equivalent | $18.56 | General |
| 01/07/2022 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $75.00 | General |
| 12/15/2021 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | ZOLGENSMA (Biological) | Honoraria | Cash or cash equivalent | $5,200.00 | General |
| Category: GENE THERAPY | ||||||
| 04/22/2021 | CSL Behring | Hizentra (Biological) | Education | In-kind items and services | $27.50 | General |
| Category: Immunology | ||||||
| 12/14/2020 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $60.00 | General |
| 12/09/2020 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $30.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 129 | 178 | $40,458 | $12,256 |
| 2022 | 3 | 124 | 186 | $41,464 | $12,487 |
| 2021 | 5 | 147 | 193 | $43,178 | $12,793 |
| 2020 | 4 | 130 | 160 | $36,340 | $9,927 |
Total Patients
530
Total Services
717
Medicare Billing
$47,463
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 86 | $18,490 | $5,917 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 33 | 51 | $10,965 | $3,467 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,669 | $1,695 | 25.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 22 | $4,334 | $1,178 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 92 | $19,780 | $6,270 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 39 | $8,385 | $2,536 | 30.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 39 | $7,683 | $2,163 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $5,616 | $1,518 | 27.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 66 | $14,190 | $4,587 | 32.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 38 | 56 | $12,040 | $3,521 | 29.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $6,732 | $1,901 | 28.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 23 | $4,531 | $1,285 | 28.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $4,563 | $1,279 | 28.0% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Facility | 2021 | 12 | 17 | $1,122 | $219.94 | 19.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 47 | 52 | $10,504 | $2,780 | 26.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 23 | 24 | $8,001 | $2,455 | 30.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 38 | $6,942 | $2,164 | 31.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 23 | 32 | $6,519 | $1,513 | 23.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $4,374 | $1,015 | 23.2% |
About Dr. Michael Cartwright, MD
Dr. Michael Cartwright, MD is a Neurology healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417987827.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Cartwright, MD has received a total of $7,742 in payments from pharmaceutical and medical device companies, with $642.86 received in 2024. These payments were reported across 67 transactions from 15 companies. The most common payment nature is "Honoraria" ($5,200).
As a Medicare-enrolled provider, Cartwright has provided services to 530 Medicare beneficiaries, totaling 717 services with total Medicare billing of $47,463. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Winston Salem, NC
- Active Since 07/03/2006
- Last Updated 11/12/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1417987827
Products in Payments
- ZOLGENSMA (Biological) $5,200
- Evrysdi (Drug) $690.00
- SPINRAZA (Biological) $285.74
- EMFLAZA (Drug) $249.73
- QALSODY (Drug) $189.78
- VILTEPSO (Drug) $103.97
- RELYVRIO (Drug) $49.09
- AGAMREE (Drug) $44.59
- Gamunex-C (Biological) $32.55
- Hizentra (Biological) $27.50
- Haegarda (Biological) $23.69
- SOLIRIS (Drug) $17.04
- POMPE - DISEASE (Drug) $12.95
- Radicava (Drug) $12.74
- LUMIZYME (Drug) $12.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Winston Salem
Dr. David Hosford, Md, Phd, MD, PHD
Neurology — Payments: $169,152
Neurology $169,152
Mustafa Siddiqui, Md, MD
Neurology — Payments: $140,528
Neurology $140,528
Dr. Mitchell Isaac, Md, MD
Neurology — Payments: $102,670
Neurology $102,670
Indrani Acosta, M.d, M.D
Neurology — Payments: $54,391
Neurology $54,391
Mrs. Rachana Gandhi Mehta, M.d, M.D
Neurology — Payments: $53,251
Neurology $53,251
Aarti Sarwal, Md, MD
Neurology — Payments: $47,980
Neurology $47,980